Literature DB >> 32014613

Interleukin 17 as a therapeutic target of acute generalized exanthematous pustulosis (AGEP).

Bruno Gualtieri1, Farzan Solimani2, Michael Hertl3, Timo Buhl4, Christian Möbs3, Wolfgang Pfützner5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32014613     DOI： 10.1016/j.jaip.2020.01.045

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  2 in total

1.  Ixekizumab for treatment of refractory acute generalized exanthematous pustulosis caused by hydroxychloroquine.

Authors:  Mohammad Munshi; Alexandra Junge; Karolina Gadaldi; Nikhil Yawalkar; Kristine Heidemeyer
Journal:  JAAD Case Rep       Date:  2020-05-17

Review 2.  Drug Triggers and Clinic of Acute Generalized Exanthematous Pustulosis (AGEP): A Literature Case Series of 297 Patients.

Authors:  Enriqueta Vallejo-Yagüe; Adrian Martinez-De la Torre; Omar S Mohamad; Shweta Sabu; Andrea M Burden
Journal:  J Clin Med       Date:  2022-01-13       Impact factor: 4.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.